Download PDF
Semin Thromb Hemost 2006; 32(7): 651-658
DOI: 10.1055/s-2006-951293
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Epidemiology and Risk Factors of Venous Thromboembolism

Walter Ageno1 , Alessandro Squizzato1 , David Garcia2 , Davide Imberti3
  • 1Department of Clinical Medicine, University of Insubria, Varese, Italy
  • 2Department of Medicine, University of New Mexico, Albuquerque, New Mexico
  • 3Department of Medicine, Ospedale di Piacenza, Piacenza, Italy
Further Information

Publication History

Publication Date:
06 October 2006 (online)

    Permissions and Reprints

ABSTRACT

Venous thromboembolism (VTE) is a common disorder that can affect apparently healthy as well as hospitalized patients. The actual incidence and prevalence of this disease are difficult to estimate because of its often silent nature. The clinical relevance of VTE is highlighted by the important rates of recurrence and mortality. The individual risk of VTE varies as a result of a complex interaction between congenital and transient or permanent acquired risk factors. Risk factors can be either intrinsic (e.g., age, obesity, history of VTE, or thrombophilia) or disease related (e.g., surgical procedures and medical disorders such as cancer, heart failure, or acute respiratory failure). The presence or absence of specific risk factors may play an important role in decisions about the type (and duration) of thromboprophylaxis/anticoagulation to be used.

KEYWORDS

Venous thromboembolism - epidemiology - risk factors - prophylaxis

REFERENCES

  • 1 Turkstra F, Kuijer P MM, van Beek E JR et al.. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism.  Ann Intern Med. 1997;  126 775-781
    CrossrefPubMedGoogle Scholar
  • 2 Meignan M, Rosso J, Gauthier H et al.. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis.  Arch Intern Med. 2000;  160 159-164
    CrossrefPubMedGoogle Scholar
  • 3 Kyrle P A, Eichinger S. Deep vein thrombosis.  Lancet. 2005;  365 1163-1174
    CrossrefPubMedGoogle Scholar
  • 4 White R H. The epidemiology of venous thromboembolism.  Circulation. 2003;  107(23 Suppl 1) I4-8
    PubMedGoogle Scholar
  • 5 Anderson Jr F A, Wheeler H B, Goldberg R J et al.. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study.  Arch Intern Med. 1991;  151 933-938
    CrossrefPubMedGoogle Scholar
  • 6 Silverstein M D, Heit J A, Mohr D N, Petterson T M, O'Fallon W M, Melton III J. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.  Arch Intern Med. 1998;  158 585-593
    CrossrefPubMedGoogle Scholar
  • 7 Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population.  J Intern Med. 1992;  232 155-160
    PubMedGoogle Scholar
  • 8 Oger E. Incidence of venous thromboembolism: a community-based study in western France.  Thromb Haemost. 2000;  83 657-660
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Kyrle P A, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women.  N Engl J Med. 2004;  350 2558-2563
    CrossrefPubMedGoogle Scholar
  • 10 Christiansen S C, Cannegieter S C, Koster T, Vandenbroucke J P, Rosendaal F R. Thrombophilia, clinical factors, and recurrent venous thrombotic events.  JAMA. 2005;  293 2352-2361
    CrossrefPubMedGoogle Scholar
  • 11 White R H, Zhou H, Romano P S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.  Ann Intern Med. 1998;  128 737-740
    CrossrefPubMedGoogle Scholar
  • 12 Ridker P M, Miletich J P, Hennekens C H et al.. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.  JAMA. 1997;  277 1305-1307
    CrossrefPubMedGoogle Scholar
  • 13 Herrmann F H, Koesling M, Schroder W et al.. Prevalence of factor V Leiden mutation in various populations.  Genet Epidemiol. 1997;  14 403-411
    CrossrefPubMedGoogle Scholar
  • 14 Bounameaux H, Hicklin L, Desmarais S. Seasonal variation in deep vein thrombosis.  BMJ. 1996;  312 284-285
    PubMedGoogle Scholar
  • 15 Wroblewski B M, Siney P, White R. Seasonal variation in fatal pulmonary embolism after hip arthroplasty.  Lancet. 1990;  335 56
    PubMedGoogle Scholar
  • 16 Prandoni P, Lensing A WA, Cogo A et al.. The long-term clinical course of acute deep venous thrombosis.  Ann Intern Med. 1996;  125 1-7
    CrossrefPubMedGoogle Scholar
  • 17 Heit J A, Mohr D N, Silverstein M D, Petterson T M, O'Fallon W M, Melton III L J. Predictors of recurrence after deep vein thrombosis and pulmonary embolism.  Arch Intern Med. 2000;  160 761-768
    CrossrefPubMedGoogle Scholar
  • 18 Heit J A, Silverstein M D, Mohr D N, Petterson T M, O'Fallon W M, Melton III L J. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.  Arch Intern Med. 1999;  159 445-453
    CrossrefPubMedGoogle Scholar
  • 19 Goldhaber S Z, Visani L, De Rosa M. for ICOPER. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).  Lancet. 1999;  353 1386-1389
    CrossrefPubMedGoogle Scholar
  • 20 Virchow R. Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Frankfurt, Germany; Medinger Sohn 1856: 219-732
    Google Scholar
  • 21 Rosendaal F R. Venous thrombosis: a multicausal disease.  Lancet. 1999;  353 1167-1173
    CrossrefPubMedGoogle Scholar
  • 22 Hansson P O, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. The Study of Men Born in 1913.  Arch Intern Med. 1997;  157 1665-1670
    CrossrefPubMedGoogle Scholar
  • 23 Goldhaber S Z, Grodstein F, Stampfer M J et al.. A prospective study of risk factors for pulmonary embolism in women.  JAMA. 1997;  277 642-645
    CrossrefPubMedGoogle Scholar
  • 24 Tsai A W, Cushman M, Rosamond W D, Heckbert S R, Polak J F, Folsom A R. Cardiovascular risk factors and venous thromboembolism incidence.  Arch Intern Med. 2002;  162 1182-1189
    CrossrefPubMedGoogle Scholar
  • 25 Abdollahi M, Cushman M, Rosendaal F R. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.  Thromb Haemost. 2003;  89 493-498
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Hansson P O, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity. Risk factors for venous thromboembolism among middle-aged men: The Study of Men Born in 1913.  Arch Intern Med. 1999;  159 1886-1890
    CrossrefPubMedGoogle Scholar
  • 27 Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism-results of the Spanish Multicentric Study on Thrombophilia.  Thromb Haemost. 1997;  77 444-451
    PubMedGoogle Scholar
  • 28 Wells P S, Blajchman M A, Henderson P et al.. Prevalence of antithrombin deficiency in healthy blood donors: a cross sectional study.  Am J Hematol. 1994;  45 321-324
    PubMedGoogle Scholar
  • 29 Tait R C, Walker I D, Perry D J et al.. Prevalence of antithrombin deficiency in the healthy population.  Br J Haematol. 1994;  87 106-112
    CrossrefPubMedGoogle Scholar
  • 30 Martinelli I, Mannucci P M, De Stefano V et al.. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.  Blood. 1998;  92 2353-2358
    PubMedGoogle Scholar
  • 31 Tait R C, Walker I D, Reitsma P H et al.. Prevalence of protein C deficiency in the healthy population.  Thromb Haemost. 1995;  73 87-93
    PubMedGoogle Scholar
  • 32 Ben-Tal O, Zivelin A, Selighson U. The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel.  Thromb Haemost. 1989;  61 50-54
    PubMedGoogle Scholar
  • 33 Crowther M A, Kelton J G. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system.  Ann Intern Med. 2003;  138 128-134
    PubMedGoogle Scholar
  • 34 Koster T, Rosendaal F R, de Ronde H, Briet E, Vandenbroucke J P, Bertina R M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.  Lancet. 1993;  342 1503-1506
    CrossrefPubMedGoogle Scholar
  • 35 Salomon O, Steinberg D M, Zivelin A et al.. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.  Arterioscler Thromb Vasc Biol. 1999;  19 511-518
    PubMedGoogle Scholar
  • 36 Ridker P M, Goldhaber S Z, Danielson E et al. for the PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.  N Engl J Med. 2003;  348 1425-1433
    CrossrefPubMedGoogle Scholar
  • 37 Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.  Blood. 1996;  88 3698-3703
    CrossrefPubMedGoogle Scholar
  • 38 Rosendaal F R, Doggen C J, Zivelin A et al.. Geographic distribution of the 20210 G to A prothrombin variant.  Thromb Haemost. 1998;  79 706-708
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Goyette P, Frosst P, Rosenblatt D S, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency.  Am J Hum Genet. 1995;  56 1052-1059
    PubMedGoogle Scholar
  • 40 Mudd S H, Skovby F, Levy H L et al.. The natural history of homocystinuria due to cystathionine beta-synthase deficiency.  Am J Hum Genet. 1985;  37 1-31
    PubMedGoogle Scholar
  • 41 Kluijtmans L A, van den Heuvel L P, Boers G H et al.. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.  Am J Hum Genet. 1996;  58 35-41
    PubMedGoogle Scholar
  • 42 Levine J S, Branch D W, Rauch J. The antiphospholipid syndrome.  N Engl J Med. 2002;  346 752-763
    CrossrefPubMedGoogle Scholar
  • 43 Samama M M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. The Sirius Study.  Arch Intern Med. 2000;  160 3415-3420
    CrossrefPubMedGoogle Scholar
  • 44 Schulman S, Granqvist S, Holmström M et al.. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism.  N Engl J Med. 1997;  336 393-398
    CrossrefPubMedGoogle Scholar
  • 45 Schulman S, Lockner D, Juhlin-Dannfelt A. The duration of oral anticoagulation after deep vein thrombosis. A randomized study.  Acta Med Scand. 1985;  217 547-552
    PubMedGoogle Scholar
  • 46 Geerts W H, Pineo G P, Heit J A et al.. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126(suppl 3) 338S-400S
    CrossrefPubMedGoogle Scholar
  • 47 Dahl O E, Gudmundsen T E, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients.  Acta Orthop Scand. 2000;  71 47-50
    CrossrefPubMedGoogle Scholar
  • 48 Demers C, Marcoux S, Ginsberg J S et al.. Incidence of venographically proved deep vein thrombosis after knee arthroscopy.  Arch Intern Med. 1998;  158 47-50
    CrossrefPubMedGoogle Scholar
  • 49 Delis K T, Hunt N, Strachan R K et al.. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.  Thromb Haemost. 2001;  86 817-821
    PubMedGoogle Scholar
  • 50 Stringer M D, Steadman C A, Hedges A R et al.. Deep vein thrombosis after elective knee surgery: an incidence study in 312 patients.  J Bone Joint Surg Br. 1989;  71 492-497
    PubMedGoogle Scholar
  • 51 Jorgensen J O, Lalak N J, North L, Hanel K, Hunt D R, Morris D L. Venous stasis during laparoscopic cholecystectomy.  Surg Laparosc Endosc. 1994;  4 128-133
    PubMedGoogle Scholar
  • 52 Sobolewski A P, Deshmukh R M, Brunson B L et al.. Venous hemodynamic changes during laparoscopic cholecystectomy.  J Laparoendosc Surg. 1995;  5 363-369
    PubMedGoogle Scholar
  • 53 Nguyen N T, Owings J T, Gosselin R et al.. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass.  Arch Surg. 2001;  136 909-916
    CrossrefPubMedGoogle Scholar
  • 54 Rahr H B, Fabrin K, Larsen J L, Thorlacius-Ussing O. Coagulation and fibrinolysis during laparoscopic cholecystectomy.  Thromb Res. 1999;  93 121-127
    CrossrefPubMedGoogle Scholar
  • 55 Sandler D A, Martin J F. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?.  J R Soc Med. 1989;  82 203-205
    CrossrefPubMedGoogle Scholar
  • 56 Goldhaber S Z, Savage D D, Garrison R J et al.. Risk factors for pulmonary embolism: the Framingham study.  Am J Med. 1983;  74 1023-1028
    PubMedGoogle Scholar
  • 57 Lindblad B, Sternby N H, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years.  BMJ. 1991;  302 709-711
    PubMedGoogle Scholar
  • 58 Baglin T P, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients.  J Clin Pathol. 1997;  50 609-610
    PubMedGoogle Scholar
  • 59 Bouthier J. The venous thrombotic risk in nonsurgical patients.  Drugs. 1996;  52(suppl) 16-29
    PubMedGoogle Scholar
  • 60 Goldhaber S Z, Dunn K, MacDougall R C. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment.  Chest. 2000;  118 1680-1684
    CrossrefPubMedGoogle Scholar
  • 61 Blom J W, Doggen C J, Osanto S, Rosendaal F R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.  JAMA. 2005;  293 715-722
    CrossrefPubMedGoogle Scholar
  • 62 Otten H M, Prins M H. Venous thromboembolism and occult malignancy.  Thromb Res. 2001;  102 V187-V194
    CrossrefPubMedGoogle Scholar
  • 63 Sorensen H T, Mellemkjaer L, Olsen J H, Baron J A. Prognosis of cancers associated with venous thromboembolism.  N Engl J Med. 2000;  343 1846-1850
    CrossrefPubMedGoogle Scholar
  • 64 Otten H M, Mathijssen J, ten Cate H et al.. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy. An underestimated phenomenon.  Arch Intern Med. 2004;  164 190-194
    CrossrefPubMedGoogle Scholar
  • 65 Macklon N S, Greer I A. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience.  Scott Med J. 1996;  41 83-86
    PubMedGoogle Scholar
  • 66 Athrash H K, Koonin L M, Lawson H W, Franks A L, Smith J C. Maternal morbidity in the United States 1979-1986.  Obstet Gynecol. 1990;  76 1055-1060
    PubMedGoogle Scholar
  • 67 Hogberg U, Innala E, Sandstrom A. Maternal mortality in Sweden.  Obstet Gynecol. 1995;  84 240-244
    PubMedGoogle Scholar
  • 68 James K, Lohr J, Deshmukh R. Venous thrombotic complications of pregnancy.  Cardiovasc Surg. 1996;  4 777-782
    PubMedGoogle Scholar
  • 69 Rutherford S, Montoro M, McGehee W, Strong T. Thromboembolic disease associated with pregnancy: an 11 year review.  Am J Obstet Gynecol. 1991;  164 286 (abst)
    PubMedGoogle Scholar
  • 70 Eldor A. The use of low molecular weight heparin for the management of venous thromboembolism in pregnancy.  Eur J Obstet Gynecol Reprod Biol. 2002;  104 3-13
    CrossrefPubMedGoogle Scholar
  • 71 Bazzan M, Donvito V. Low molecular weight heparin during pregnancy.  Thromb Res. 2001;  101 V175-V186
    CrossrefPubMedGoogle Scholar
  • 72 Rosendaal F R, Van Hylckama Vlieg A, Tanis B C, Helmerhorst F M. Estrogens, progestogens and thrombosis.  J Thromb Haemost. 2003;  1 1371-1380
    CrossrefPubMedGoogle Scholar
  • 73 Nelson H D, Humphrey L L, Nygren P, Teutsch S M, Allan J D. Postmenopausal hormone replacement therapy: scientific review.  JAMA. 2002;  288 872-881
    CrossrefPubMedGoogle Scholar
  • 74 Samama M M, Dahl O E, Mismetti P et al.. Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis.  J Thromb Haemost. 2003;  1(suppl 1) OC436 (abst)
    PubMedGoogle Scholar
  • 75 Samama M M, Dahl O E, Quinlan D J, Mismetti P, Rosencher N. Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.  Haematologica. 2003;  88 1410-1421
    PubMedGoogle Scholar
  • 76 Cohen A T, Alikhan R, Arcelus J et al.. A risk assessment model for identifying medical patients who should receive thombopropylaxis.  J Thromb Haemost. 2003;  1(suppl 1) OC437 (abst)
    PubMedGoogle Scholar

Walter AgenoM.D. U.O. 

Medicina Interna, Ospedale di Circolo

Viale Borri 57, 21100 Varese, Italy

Email: agewal@yahoo.com

      >